Please login to the form below
DigitalMR forms partnership with Italian healthcare comms agency
Brandnew Marketing Communications will distribute DigitalMR solutions across Italy
London-based social media research firm DigitalMR has formed a partnership with Italian healthcare marketing group, Brandnew Marketing Communications (BNMC).
The two companies will work together to develop online marketing and research tools, with the aim of improving healthcare and wellbeing customer engagement.
Letizia Affinito, founder and MD of BNMC, said: “This partnership will allow us to create marketing communications in a new way, using insights to improve customer engagement and amplify positive word of mouth, thus creating more effective campaigns for our clients.”
With offices in Rome and Milan, BNMC will drive distribution of DigitalMR online platforms and solutions throughout Italy.
“Next generation market research is about co-creating among brand and product advocates, working in partnership with marketing to produce optimised communications campaigns,” said Michalis Michael, founder and group MD at DigitalMR.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Editorial Team Leader, Medical Communications, Oxford
-
Competitive Salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Graduate Business Analyst, Healthcare Communications – Pharma/ S...
-
Highly competitive salary
-
Head of Copy
-
£ competitive
- Client Services Director, MRNA/ Covid 19, Medical Communications...
-
Highly competitive salary
- AstraZeneca's Enhertu receives FDA grant for priority review
- Why pharma must get smart in its approach to customer engagement
- AstraZeneca’s Imfinzi and tremelimumab show unprecedented survival rate in liver cancer patients
- Pfizer’s Cibinqo granted FDA approval for adults with moderate-to-severe atopic dermatitis
- GSK appoint Tony Wood as chief scientific officer
- Anthem PR appoints new managing director Rebecca Fergusson
- PM announces plans to lift England’s COVID-19 restrictions
- Merck and Eisai share crucial phase 3 trial results for advanced endometrial carcinoma treatment
- Developing Innovative Digital Strategies to Engage Patients
- GSK appoint Tony Wood as chief scientific officer
- Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results
- Cervical Cancer Prevention Month
PMHub
certain health
Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...
Latest intelligence
- Cervical Cancer Prevention Month
- In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...
- 6 critical success factors for flawless execution of a rapid first commercial launch
- Annemarie Armstrong, Executive Vice President, US Head of Client Services, shares the key considerations for launching a first commercial product, particularly on a rapid timeline....
- Hybrid working: Insights and tips for success
- Porterhouse Medical has thrived by embracing a hybrid approach to work. Our article looks at hybrid working and provides some tips for success...
